Equities
Health CarePharmaceuticals and Biotechnology
  • Price (NOK)0.433
  • Today's Change0.021 / 5.10%
  • Shares traded3.58m
  • 1 Year change-90.63%
  • Beta-0.4866
Data delayed at least 15 minutes, as of Feb 10 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.

  • Revenue in NOK (TTM)1.82m
  • Net income in NOK-123.69m
  • Incorporated2006
  • Employees28.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
2cureX AB26.79k3.28m45.99m0.008.2768.57--1,717.040.20680.20680.00120.02490.0041--0.0148--50.01-45.04179.24-49.69-12,972.00-44,478.8912,228.00-109,947.80----0.00------88.14------
Larkberget AB270.00k-37.99m46.67m1.00--0.788--172.87-1.79-1.790.01272.790.0031--0.270225,200.00-43.82-16.31-47.28-17.54-----14,069.77-81.71----0.00---94.13---25.83------
Acousort AB6.02m-13.24m58.28m16.00--2.92--9.69-0.7188-0.71880.31010.88140.2799-0.027449.25350,937.50-61.61-48.79-81.29-71.44101.2163.17-220.12-285.724.51--0.00---14.4020.6111.77------
Chosa Oncology AB768.22k-6.44m73.12m----4.23--95.18-0.0766-0.07660.00960.20440.0382--0.8639---32.00-55.65-35.30-67.69643.24---837.66-792.50---49.050.00---39.73-62.5659.93------
Lifecare ASA1.82m-123.69m82.73m28.00------45.36-2.48-2.480.0379-0.110.0168--0.158255,272.73-115.30-52.64-194.19-61.98-----6,864.75-277.39----1.17---26.1036.13-103.52------
IDL Diagnostics AB (publ)55.92m-42.12m86.88m22.00--0.542--1.55-0.1706-0.17060.22660.64950.32636.595.262,372,364.00-24.58-29.04-26.98-31.1421.531.70-75.32-157.603.29--0.0843--33.45164.6228.41--18.85--
Opsy Holding AB4.42m-20.03m92.51m7.00--55.91--20.91-20.83-20.830.63210.12160.294--7.632,064,500.00-133.11-117.68-201.35-142.11154.30---452.72-----216.840.463-------43.22------
Spago Nanomedical AB (publ)468.22k-28.45m93.92m7.00--2.85--200.59-0.0513-0.05130.00080.04650.0115--4.3962,428.57-69.64-30.44-81.41-32.48-----6,076.43-3,410.33---------77.135.0218.32------
Biosergen AB0.00-32.78m106.17m2.00--4.89-----13.74-13.740.008.630.00----0.00-152.65---191.42--------------0.00------29.00------
Coegin Pharma AB0.00-22.12m108.22m3.00--8.67-----0.7859-0.78590.000.46810.00----0.00-85.07-133.34-91.51-179.59------------0.00------15.00------
Active Biotech AB publ0.00-41.25m109.30m5.00--13.33-----0.0737-0.07370.000.00290.00----0.00-241.37-94.38-927.66-120.44-------3,355.24----0.0816------13.98------
Annexin Pharmaceuticals AB (publ)0.00-39.53m112.69m4.00--4.22-----5.98-5.980.003.530.00----0.00-150.00-137.53-190.93-169.50------------0.00------26.58------
Exact Therapeutics AS0.00-72.20m118.94m12.00--1.76-----1.40-1.400.001.070.00----0.00-108.82-43.50-168.39-50.76-----------20.180.0052-------8.27--1.47--
Alligator Bioscience AB45.26m-83.27m120.27m13.00------2.66-2.16-2.160.6369-0.05920.5013--9.35938,822.30-92.22-97.96---155.50-----183.96-569.04----1.33---0.585167.685.91------
Glycorex Transplantation AB (publ)42.79m-7.56m122.69m20.00--3.2148.672.87-0.0917-0.09170.51740.47190.74421.455.201,997,000.00-13.15-15.79-17.51-18.6681.6887.06-17.67-44.851.56-15.830.1599--17.35-0.529663.97------
Data as of Feb 10 2026. Currency figures normalised to Lifecare ASA's reporting currency: Norwegian Krone NOK

Institutional shareholders

3.82%Per cent of shares held by top holders
HolderShares% Held
Nordea Investment Management AB (Norway)as of 31 Dec 2025728.84k3.82%
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.